Generation of T Cells of Desired HLA Restriction Specific for Epitopes of a Self-Antigen, WT1, for the Adoptive Immunotherapy of WT1 Positive Malignancies Using A Panel of Artificial Antigen Presenting Cells Expressing Prevalent HLA Alleles.

被引：0
|
作者：
Doubrovina, Ekaterina
Hasan, Aisha
Oflaz-Sozmen, Banu
Selvakumar, Annamalai [1 ]
Sadelain, Michel W. [2 ]
O'Reilly, Richard J. [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Ctr Cell Engn & Mol Pharmacol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Pediat BMT, New York, NY 10021 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1567 / 1568
页数：2
相关论文
共 41 条
  • [1] A panel of artificial antigen-presenting cells (AAPC) expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both subdominant and dominant viral-epitopes for adoptive therapy
    Hasan, Aisha
    Kollen, Wouter J.
    Selvakumar, A.
    Trivedi, D.
    Sadelain, M.
    O'Reilly, Richard J.
    BLOOD, 2007, 110 (11) : 763A - 763A
  • [2] Identification of novel WT1 epitopes by sensitization of human T cells with overlapping pentadecapeptides spanning the WT1 protein for the targeted adoptive immunotherapy of leukemia
    Doubrovina, E
    Dupont, J
    Trivedi, D
    O'Reilly, RJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 63 - 63
  • [3] A panel of artificial antigen presenting cells (AAPC) permits immediate sensitization and rapid generation of virus-specific T-cells of desired HLA restriction for adoptive immunotherapy.
    Hasan, Aisha N.
    Kollen, Wouter J.
    Trivedi, Deepa
    Selvakumar, A.
    Sadelain, Michel
    O'Reilly, Richard J.
    BLOOD, 2006, 108 (11) : 933A - 933A
  • [4] Generation of antigen-specific cytotoxic T lymphocytes targeting WT1 using activated B cells
    Yun, Sun Ok
    Baek, Kyung Won
    Shin, Hee Young
    Kang, Hyoung Jin
    BONE MARROW TRANSPLANTATION, 2019, 54 : 188 - 188
  • [5] A Panel of Artificial APCs Expressing Prevalent HLA Alleles Permits Generation of Cytotoxic T Cells Specific for Both Dominant and Subdominant Viral Epitopes for Adoptive Therapy
    Hasan, Aisha N.
    Kollen, Wouter J.
    Trivedi, Deepa
    Selvakumar, Annamalai
    Dupont, Bo
    Sadelain, Michel
    O'Reilly, Richard J.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (04): : 2837 - 2850
  • [6] Artificial antigen-presenting cells permit selective in vitro generation of CMV-specific T-cells of desired HLA allelic restriction for adoptive immunotherapy in recipients of HLA disparate allografts.
    Trivedi, D
    Kollen, WJ
    Barnett, L
    Sadelain, M
    O'Reilly, RJ
    BLOOD, 2005, 106 (11) : 377A - 378A
  • [7] Wilms' tumor antigen-1 (WT1) presentation and specific T cell-priming by human dendritic cells electroporated with WT1 mRNA
    Van Driessche, A
    Ponsaerts, P
    Nijs, G
    Lenjou, M
    Gao, L
    Van Bockstaele, DR
    Stauss, HJ
    Van Tendeloo, VFI
    Berneman, ZN
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 53 - 54
  • [8] Identification of HLA-A11 restricted T cell epitope of Wilms' tumor 1 (WT1) antigen and isolation of WT1-specific TCR
    Jiang, Min
    Sun, Wenqiao
    Lu, Dan
    He, Juanhua
    Wang, Jie
    Tan, Shuguang
    Gao, George F.
    CHINESE SCIENCE BULLETIN-CHINESE, 2022, 67 (17): : 1945 - 1957
  • [9] Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination
    Pospori, Constandina
    Xue, Shao-An
    Holler, Angelika
    Voisine, Cecile
    Perro, Mario
    King, Judith
    Fallah-Arani, Farnaz
    Flutter, Barry
    Chakraverty, Ronjon
    Stauss, Hans J.
    Morris, Emma C.
    BLOOD, 2011, 117 (25) : 6813 - 6824
  • [10] IN T-CELL LINES DUALLY SENSITIZED WITH ANTIGENS FROM EBV AND CMV OR FROM EBV AND WT1 THE T-CELLS SPECIFIC FOR CMV OR WT1 ARE OFTEN RESTRICTED BY HLA ALLELES THAT DIFFER FROM THOSE RESTRICTING T-CELLS SPECIFIC FOR EBV
    Doubrovina, E.
    Hasan, A.
    Prockop, S.
    O'Reilly, R. J.
    CYTOTHERAPY, 2019, 21 (05) : S28 - S28
12345